Table:
begin	end	state
1	19	cytoplasmic
20	39	transmembrane
40	44	non-cytoplasmic
45	70	transmembrane
71	107	cytoplasmic
108	132	transmembrane
133	144	non-cytoplasmic
145	163	transmembrane
164	168	cytoplasmic
169	191	transmembrane
192	202	non-cytoplasmic
203	223	transmembrane
224	255	cytoplasmic
256	279	transmembrane
280	314	non-cytoplasmic
315	341	transmembrane
342	352	cytoplasmic
353	378	transmembrane
379	387	non-cytoplasmic
388	406	transmembrane
407	412	cytoplasmic
413	429	transmembrane
430	464	non-cytoplasmic
465	487	transmembrane
488	500	cytoplasmic

Input:
>RR42_RS34870 FitnessBrowser__Cup4G11:RR42_RS34870
MELIDHLALGFSTALSLQNLAYAFLGCVLGTLIGVLPGLGPLATIAMLLPVTYTLPPVAA
LIMLAGIYYGAQYGGSTTAILVNLPGESSSVVTTIDGYQMARRGRAGVALATAGLGSFFA
GCVATLILAAFATPLSELAFKFGPAEYFSLMCLGLIGAVVLASGSLPKAVAMIVLGLLLG
LIGTDVNSGAARFSFDIPELTDGIDFVALAMGMFGFAEIIANLEQKEARETFTDSVTNLW
PTREDFRRMIPAVLRGTFLGSALGILPGGGAALASFAAYSLEKKTSKYAHEFGKGAIEGV
AGPESANNAAAQTSFIPLLTLGIPPNAVMALMVGAMTIHNIQPGPQVMTSNPALFWGLIA
SMWIGNLMLIILNLPMIGVWVKLLTVPYRYLYPAILVFCGIGVYSVNNQTFDVFMAAGFG
IIGYLFLKLKCEPAPLLLGFVLGPMMEENFRRSLLLSRGEFTVFVTRPLSLGLLIAAASL
VAIVALPSIKAKREEAFQEE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server